Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 3

Rasagiline – a novel MAO B inhibitor in Parkinson’s disease therapy

Total article views   Abstract views HTML views PDF downloads Totals
4,633 Dovepress* 4,633 0+ 1,334 4,633
Totals 4,633 0 1,334 4,633
*Since 15 July 2007
+Since July 2016

View citations on Google Scholar